Company
T2 Biosystems, Inc. (0001492674)
Standardized SEC financial data for T2 Biosystems, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001492674 · Surgical & Medical Instruments & Apparatus.
Gross margin
18.0%
Operating margin
-690.5%
Net margin
-696.2%
Revenue growth (YoY)
-67.8%
Return on equity
178.6%
Free cash flow
-$48.3M
Current ratio
0.45×
EPS (diluted)
$-19.19
Ratios for fiscal year 2023, standardized from SEC filings.
Income statement
| USD | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|
| Revenue | — | $8.3M | $18.1M | $28.1M | $22.3M | $7.2M |
| Cost of revenue |
Balance sheet
| USD | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $50.8M | $11.0M | $16.8M | $22.2M | $11.9M | $16.2M |
| Inventory |
Cash flow
| USD | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$40.1M | -$45.4M | -$43.2M | -$38.9M | -$50.6M | -$48.1M |
| Capital expenditures |
Get 0001492674 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001492674/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001492674/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"